NIH grant of $2.2 million could help researchers target two oncogenes, potentially leading to therapies for melanoma, lung cancer, and other tumors

UC Riverside-led study is the first to show how tofacitinib affects epithelial cells lining the gut

UC Riverside-led study tested the effects of microgravity on intestinal epithelial cells

UC Riverside mouse study finds early exposure to sounds can address hypersensitivity to noise associated with Fragile X Syndrome

The shape and architecture of collagen and elastin fibers can improve our understanding of lung diseases, including the one associated with vaping

UC Riverside-led research could aid regenerative stem cell therapies

Research is supported by a five-year grant to UC Riverside from the National Institutes of Health

UC Riverside-led mouse study focuses on cannabis-like molecules that augment feeding behavior

School of Medicine’s Nicholas DiPatrizio will lead a team tasked with assessing the impact of long-term cannabis exposure on metabolic health and disease

UC Riverside biomedical scientist’s decades-long work moves to clinical trials

Research could help reduce females’ susceptibility to several diseases, such as Fragile X and Rett syndromes

Multiple sclerosis is an autoimmune disease that affects more than 2.3 million people worldwide. This debilitating condition periodically shutters communication between the brain and other parts of the body, resulting in symptoms that range from numbness and tingling in the arms and legs to blindness and paralysis. While treatments are...

Scientists unlock new molecular secrets to unravel the mystery

Novel agents 135H11 and 135H12 move research closer to drug development

Donovan Argueta , a first-generation college graduate at the University of California, Riverside, has won a Ford Foundation 2018 Dissertation Fellowship. The $25,000 fellowship begins June 1, 2018. As a fellow, Argueta will receive additional support to attend an annual conference of the Ford Foundation fellows this fall. The mission...